Secondary stroke prevention in patients with atrial fibrillation (AF) who experience an ischemic stroke (IS) despite oral anticoagulation remains challenging, and strategies have focused on antithrombotic optimization or left atrial appendage occlusion. Adjunctive statin therapy might reduce early vascular risk and...
G. Merlino, R. Ornello, L. D'Anna et al.· Therapeutic Advances in Neur...· 0 citations
Ischemic stroke remains a leading cause of death and long-term disability, and current reperfusion therapies do not prevent progressive neuronal loss and neurological decline. Thus, therapeutic strategies targeting intracellular pathways underlying post-ischemic neurodegeneration remain a critical unmet clinical need...
Nunzio Perta, Stefano Fumagalli, C. Villani et al.· Cell Death & Disease· 0 citations
These findings identify miR-143, miR-150, let-7a, and miR-181b as candidate pharmacodynamic biomarkers of RIC biological activity and highlight the need for external validation in larger outcome-linked cohorts.
Rohan Mahesh Patil, Susanna Diamanti, Simone Beretta et al.· Journal of Cerebral Blood Fl...· 0 citations
Potential causes of breakthrough ischemic stroke are identifiable in about half of breakthrough strokes and are associated with higher risk of recurrence compared with those without, warranting individualized approaches.
Federico De Santis, Matteo Foschi, Francesca Gabriele et al.· Journal of Neurology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.